Endovascular treatments for small veins

Endoperivenous treatment with LASEmaR® 800 

The Endoperivenous treatment FLEBOLASER solves the venous disease of the tortuous varicose troncs, reticular varicose vein, perforating veins and vascular malformations, thanks to the maximum selectivity of the beam, which avoids thermal damages to the surrounding tissues. 

The phototermolotical selective effect, working with diode wavelength 808nm vaporizes: 

  • the “endoluminal” hemoglobin and those contained in “vasa venarum” or “vasa vasorum”
  • the “myoglobin” of the parietal muscle tonka.

The immediate result is a thermal endothelium and a damage of the myoglobin muscle component, associated to the wrinkling of the collagen.
The long term result is the complete disappearance of the vessel. 

  • info_outline Read More
    For the treatment of the reticular veins with the diode laser 808nm (LASEmaR® 800), the endoperivenous method considers the use of particular affordable optical single use fibers FTF System. They permit to the health worker to save time and money, offering the warranty and the security of a completely outpatient treatment in an always sterile field.

    ADVANTAGES OF THE ENDOPERIVENOUS LASER

    • Simplicity and repeatability of execution
    • local or cryogenic anesthesia
    • No limit of vessels to treat in just one session
    • Mini-invasive
    • Immediate mobilization
    • No hemorrhage and scars
    • Social and working continuity
    • No postoperative pain
    • Remarkable appreciation by patients
    • Good and permanent results in 99% of the cases (based on a follow up major than 10 years)

    Reticular Veins Treatment- LASEmaR® 800

    Reticular and Teleangectasias

Find your laser

Are you interested in a laser or in an accessory?

commentAsk for consulationcomment
REQUEST FOR CONSULTATION

Do you need help? Fill in the form and we will help you solve it.

!

!

Disclosures
Some of the information contained in this website are exclusively directed to healthcare professionals, in compliance with art. 21 of the Decree n. 46 of February 24th, 1997 and subsequent modifications and integrations, and the Guidelines of the Italian Ministry of Health of March 28th, 2013. The possibility to continue browsing and access to the content relating to products, technical descriptions and commercial offers is subject to the statement made by the user, under his own responsibility, to be a healthcare professional. The simple visitors will be redirected to institutional page of Eufoton.
Cookie Policy

This website uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Find out more by clicking here. ABILITA or DISABILITA.

By pressing Continue I declare under my own responsibility to be a healthcare provider and continuing to browse I declare to accept the cookie information.

I am a health worker
Continue arrow_forward
I am a visitor
Home arrow_forward